Embotrap III 支架截留器在实际应用中的初步经验。

IF 1.7 4区 医学 Q3 Medicine
Interventional Neuroradiology Pub Date : 2024-10-01 Epub Date: 2022-12-15 DOI:10.1177/15910199221142097
Osama Omrani, Nema Hafezi-Bakhtiari, Peter DeSouza, Christos Nikola, Ken Wong, Joseph Lansley, Permesh Dhillon, Levansri Makalanda, Nathan Chan, Thomas Harrison, Alex Andrews, Isabel Siow, Keng Siang Lee, Leonard Yeo, Oliver Spooner, Pervinder Bhogal
{"title":"Embotrap III 支架截留器在实际应用中的初步经验。","authors":"Osama Omrani, Nema Hafezi-Bakhtiari, Peter DeSouza, Christos Nikola, Ken Wong, Joseph Lansley, Permesh Dhillon, Levansri Makalanda, Nathan Chan, Thomas Harrison, Alex Andrews, Isabel Siow, Keng Siang Lee, Leonard Yeo, Oliver Spooner, Pervinder Bhogal","doi":"10.1177/15910199221142097","DOIUrl":null,"url":null,"abstract":"<p><strong>Materials and methods: </strong>We performed a retrospective review of our prospectively maintained database to identify all patients treated with the Embotrap 3 stent-retriever between January 2021 and January 2022. We recorded the baseline demographics, NIHSS, ASPECT score and clot characteristics, first pass and final eTICI scores, complications and 90 day mRS.</p><p><strong>Results: </strong>One hundred and ten patients met the inclusion criteria, average age 69 ± 14 years, 50% were male (<i>n</i> = 55). The median NIHSS at presentation was 18 (range 3-30) and 58.2% received IV tPA prior to MT. The median ASPECT score on plain CT was 8 with average clot length 20.2 ± 14.8 mm (<i>n</i> = 93). The first pass effect (FPE) was seen in 41.8% of cases with modified FPE seen in 59.1%. A 24-hour CT scan (<i>n</i> = 97) showed median ASPECTs of 7. 43.8% of patients achieve mRS ≤ 2 at 90-day mRS (<i>n</i> = 64).</p><p><strong>Conclusion: </strong>The Embotrap 3 stent-retriever has a high rate of FPE and final recanalization in this real world cohort of patients.</p>","PeriodicalId":14380,"journal":{"name":"Interventional Neuroradiology","volume":" ","pages":"663-671"},"PeriodicalIF":1.7000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11569467/pdf/","citationCount":"0","resultStr":"{\"title\":\"The initial experience with the Embotrap III stent-retriever in a real world setting.\",\"authors\":\"Osama Omrani, Nema Hafezi-Bakhtiari, Peter DeSouza, Christos Nikola, Ken Wong, Joseph Lansley, Permesh Dhillon, Levansri Makalanda, Nathan Chan, Thomas Harrison, Alex Andrews, Isabel Siow, Keng Siang Lee, Leonard Yeo, Oliver Spooner, Pervinder Bhogal\",\"doi\":\"10.1177/15910199221142097\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Materials and methods: </strong>We performed a retrospective review of our prospectively maintained database to identify all patients treated with the Embotrap 3 stent-retriever between January 2021 and January 2022. We recorded the baseline demographics, NIHSS, ASPECT score and clot characteristics, first pass and final eTICI scores, complications and 90 day mRS.</p><p><strong>Results: </strong>One hundred and ten patients met the inclusion criteria, average age 69 ± 14 years, 50% were male (<i>n</i> = 55). The median NIHSS at presentation was 18 (range 3-30) and 58.2% received IV tPA prior to MT. The median ASPECT score on plain CT was 8 with average clot length 20.2 ± 14.8 mm (<i>n</i> = 93). The first pass effect (FPE) was seen in 41.8% of cases with modified FPE seen in 59.1%. A 24-hour CT scan (<i>n</i> = 97) showed median ASPECTs of 7. 43.8% of patients achieve mRS ≤ 2 at 90-day mRS (<i>n</i> = 64).</p><p><strong>Conclusion: </strong>The Embotrap 3 stent-retriever has a high rate of FPE and final recanalization in this real world cohort of patients.</p>\",\"PeriodicalId\":14380,\"journal\":{\"name\":\"Interventional Neuroradiology\",\"volume\":\" \",\"pages\":\"663-671\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11569467/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Interventional Neuroradiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/15910199221142097\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/12/15 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Interventional Neuroradiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/15910199221142097","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/12/15 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

材料和方法:我们对前瞻性维护的数据库进行了回顾性审查,以确定2021年1月至2022年1月期间使用Embotrap 3支架回流器治疗的所有患者。我们记录了基线人口统计学、NIHSS、ASPECT 评分和血栓特征、首次通过和最终 eTICI 评分、并发症和 90 天 mRS:110名患者符合纳入标准,平均年龄(69 ± 14)岁,50%为男性(n = 55)。发病时的 NIHSS 中位数为 18(3-30),58.2% 的患者在 MT 前接受了静脉 tPA 治疗。CT 平扫的 ASPECT 评分中位数为 8 分,血栓平均长度为 20.2 ± 14.8 mm(n = 93)。41.8%的病例出现首过效应(FPE),59.1%的病例出现改良FPE。24 小时 CT 扫描(n = 97)显示中位 ASPECTs 为 7,43.8% 的患者在 90 天后 mRS≤2 (n = 64):结论:Embotrap 3支架截留器在现实世界的患者群中具有较高的FPE率和最终再通率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The initial experience with the Embotrap III stent-retriever in a real world setting.

Materials and methods: We performed a retrospective review of our prospectively maintained database to identify all patients treated with the Embotrap 3 stent-retriever between January 2021 and January 2022. We recorded the baseline demographics, NIHSS, ASPECT score and clot characteristics, first pass and final eTICI scores, complications and 90 day mRS.

Results: One hundred and ten patients met the inclusion criteria, average age 69 ± 14 years, 50% were male (n = 55). The median NIHSS at presentation was 18 (range 3-30) and 58.2% received IV tPA prior to MT. The median ASPECT score on plain CT was 8 with average clot length 20.2 ± 14.8 mm (n = 93). The first pass effect (FPE) was seen in 41.8% of cases with modified FPE seen in 59.1%. A 24-hour CT scan (n = 97) showed median ASPECTs of 7. 43.8% of patients achieve mRS ≤ 2 at 90-day mRS (n = 64).

Conclusion: The Embotrap 3 stent-retriever has a high rate of FPE and final recanalization in this real world cohort of patients.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.80
自引率
11.80%
发文量
192
审稿时长
6-12 weeks
期刊介绍: Interventional Neuroradiology (INR) is a peer-reviewed clinical practice journal documenting the current state of interventional neuroradiology worldwide. INR publishes original clinical observations, descriptions of new techniques or procedures, case reports, and articles on the ethical and social aspects of related health care. Original research published in INR is related to the practice of interventional neuroradiology...
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信